Sujay Kango

Insider Reports History

Entity
Individual
Location
1028 Chambers Court, Bridgewater, NJ
Signature
/s/ David M. Urso, as attorney in fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sujay Kango:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INFINITY PHARMACEUTICALS, INC. Director Stock Option (right to buy) 90K Mar 30, 2022 Direct
MEI Pharma, Inc. Director Stock Option (Right to Buy) 10K Sep 29, 2023 Direct
ACCELERON PHARMA INC EVP, Chief Commercial Officer Common Stock 0 $29.37 Nov 19, 2021 Direct
ACCELERON PHARMA INC EVP, Chief Commercial Officer Option to Purchase Common Stock 0 Nov 19, 2021 Direct

Insider Reports Filed by Sujay Kango

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MEIP MEI Pharma, Inc. Sep 29, 2023 1 $0 4 Oct 12, 2023 Director
MEIP MEI Pharma, Inc. Jul 5, 2022 1 $0 4 Jul 7, 2022 Director
INFI INFINITY PHARMACEUTICALS, INC. Mar 30, 2022 1 $0 4 Mar 31, 2022 Director
INFI INFINITY PHARMACEUTICALS, INC. Mar 30, 2022 0 $0 3 Mar 31, 2022 Director
MEIP MEI Pharma, Inc. Nov 22, 2021 1 $0 4 Nov 23, 2021 Director
MEIP MEI Pharma, Inc. Nov 22, 2021 0 $0 3 Nov 23, 2021 Director
XLRN ACCELERON PHARMA INC Nov 19, 2021 5 $0 4 Nov 22, 2021 EVP, Chief Commercial Officer
XLRN ACCELERON PHARMA INC Sep 27, 2021 3 -$672K 4 Sep 27, 2021 EVP, Chief Commercial Officer
XLRN ACCELERON PHARMA INC Sep 21, 2021 3 -$547K 4 Sep 22, 2021 EVP, Chief Commercial Officer
XLRN ACCELERON PHARMA INC Feb 12, 2021 1 -$116K 4 Jun 8, 2021 EVP, Chief Commercial Officer